Blood cancers, Children's cancers, High grade lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2/3
This trial looked at a drug called rituximab alongside chemotherapy for B cell lymphoma in children and young people up to the age of 18.
The trial was supported by Cancer Research UK. It was open for people to join between 2011 and 2017. The team published the results in 2020.
Recruitment start: 28 November 2011
Recruitment end: 13 June 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Amos Burke
Alex Hulme Foundation
Bloodwise
Cancer Research UK
Institute Gustave-Roussy
Roche
Syneos Health (formerly InVentiv Health)
University of Birmingham
This is Cancer Research UK trial number CRUK/11/038.
Last reviewed: 3 May 2022
CRUK internal database number: 8275
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
